Alinia 100 mg in 5 mL Oral Suspension
RxNorm 404419
Concept Hierarchy & Relationship Mapping
RxNorm Concept Unique Identifier (RxCUI) 404419 represents a standardized clinical drug concept used for cross-system interoperability. This concept aggregates multiple Atom IDs (AUIs), which are specific naming variations and synonyms used across pharmaceutical databases to ensure accurate medication mapping for: Alinia 100 mg in 5 mL Oral Suspension.
The following semantic concepts and normalized strings are associated with this clinical entity:
This clinical crossover tool is designed for healthcare professionals, pharmacists, and data analysts to safely compare substitute products and manage medication interoperability.
PSNPrescribable
Prescribable Name (PSN):
Alinia 100 mg in 5 mL Oral Suspension
(Atom ID: 8261010)
SYPrescribable
Synonym (SY):
Alinia 100 mg per 5 mL Oral Powder for Suspension
(Atom ID: 5911578)
SYPrescribable
Synonym (SY):
Alinia 20 mg/ML Oral Suspension
(Atom ID: 1666518)
SBDPrescribable
Semantic Branded Drug (SBD):
Nitazoxanide 20 mg/ML Oral Suspension [Alinia]
(Atom ID: 1666516)
Patient Education
Nitazoxanide
Nitazoxanide is used to treat diarrhea in children and adults caused by the protozoa Cryptosporidium or Giardia. Protozoa are suspected as the cause when diarrhea lasts more than 7 days. Nitazoxanide is in a class of medications called antiprotozoal agents. It works by stopping the growth of certain protozoa that cause diarrhea.
[Learn More]
* Please review the disclaimer below.